DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174426

A study to compare the efficacy of ormeloxifene with norethisterone and conventional oral contraceptive pills

Monica Chauhan, Neena Gupta, Seema Dwivedi, Shaily Agarwal

Abstract


Background: Dysfunctional uterine bleeding is one of the commonest conditions for which patients seek advice in gynaecological outpatient department. Objective of present study was comparative evaluation of ormeloxifene with norethisterone and conventional oral contraceptive pills in dysfunctional uterine bleeding.

Methods: This randomized study was conducted on 300 cases of dysfunctional uterine bleeding and they were distributed into three groups. group I were given ormeloxifene 60 mg biweekly for first 12 weeks followed by 60 mg weekly for next 12 weeks. Group II were given norethisterone 5 mg BD from 5th to 25th day of cycle and group III were given oral contraceptive pills from 5th to 25th day of cycle.

Results: Subjective improvement was outstanding in group I in comparison to other two groups. There was also statistically significant increase in Hb g/dl and statistically significant decrease in endometrial thickness.

Conclusions: Ormeloxifene was found to be superior to both norethisterone and conventional OCPs.


Keywords


Dysfunctional uterine bleeding, Endometrial thickness, Hemoglobin

Full Text:

PDF

References


Edlund M, Magnusson C, Von Schoultz B. Quality of life, a Swedish survey of 2200 women with DUB. London Royal Society of Medicine Press;1994:36-7.

National Statistics Online (2001). Available at www.statistics.gov.uk/ census 2001 /pop 2001/england wales.asp.2002. Accessed on 21st April 2002.

Chandra BS, Kumar SS, Shankar BT, Chandra GRS, Chandra RA, Prasad KS. Ormeloxifene a selective estrogen receptor modulator, for treatment of dysfunctional menorrhagia. J Obstet Gynecol lnd. 2004;54(1):56-59.

Nicholson WK, Ellison SA, Grason H, Powe NR. Patterns of ambulatory care use for gynaecological conditions: a national study. Am J Obstet Gynecol. 2001;180:523-30.

Konar H. Abnormal menstrual bleeding. D. C Dutta‟s Textbook of Gynaecology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers;2014:180.

Osborne CK, Zhao H, Fuqua SA. Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol. 2000;18(17):3172-86.

Ravibabu K, Palla J, Chintada GS. A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding. JCDR. 2013;7(11):2534-6.

Dhananjay BS, Nanda SK. The role of sevista in the management of dysfunctional uterine bleeding. J Clin Diagn Res. 2013;7(1):132-4.

Falcone T, Desjardins C, Borque J. Dysfunctional uterine bleeding in adolescents. J Reprod Med. 1994;39(10):761.

Chitrangada, Singh SK, Nag S. A double blinded randomized controlled trial to compare Ormeloxifene and Norethisterone in the treatment of dysfunctional uterine bleeding. IOSR-JDMS. 2014;13(1):52-56.

Bhattacharya TK. Efficacy of SERMs; ormeloxifene in DUB. JSAFOG. 2010;2(3):207-211.

Kriplani A, Kulshreshtha. Efficacy and safety of ormeloxifene in management of uterine bleeding. Chapter 30, 6th ed. London, Butterworths;2001:560-580.